Here are five Johnson & Johnson investments:
- The venture capital arm led a $78 million funding round for Perceive Therapeutics, a biotech company focusing in ophthalmology.
- HistoSonics, the developer of a sonic beam therapy, received $85 million in a funding round led by Johnson & Johnson innovation.
- In December, Johnson & Johnson joined in a $60.75 million series A funding round for SonoThera, a biotech genetic therapy company.
- Johnson & Johnson Innovation participated in the $25 million series B funding round for medical device cybersecurity company MedCrypt.
- The venture capital arm co-led a $10 million funding round for DocSpera, a surgical workflow automation company.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.